Cell therapies: Super charging the immune system
Related
Watch on demand our first session of 'New Directions in Immuno-oncology: Response and Resistance' held on February 3, 2021
Webinar objectives
- Describe Hedgehog signaling in immune cells during the anti-tumour response
- Explain HLA-E and NKG2A as a novel immune checkpoint axis in bladder cancer
- Discuss the engineering of CAR T cells with improved persistence and resistance to the solid tumor microenvironment
Abcam is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. Interested in receiving P.A.C.E credit for this educational session? Request credit here!
Speakers
- Maike de la Roche, University of Cambridge, UK
- Hedgehog signaling in immune cells during the anti-tumour response
- Timestamp: 8:08 - 31:25
- Uriel Moreno, Johnson & Johnson, USA
- Plasticity of natural killer cells in the tumor microenvironment
- Timestamp: 32:35 - 1:00:30
- Deborah Moore-Lai, Abcam, USA
- Proteins and reagents for cell therapy research
- Timestamp: 1:01:20 - 1:19:10
- Amir Horowitz, Icahn School of Medicine at Mount Sinai, USA
- HLA-E and NKG2A as a novel immune checkpoint axis in bladder cancer
- Timestamp: 1:20:21 - 1:55:33